Apollo Global Management stock gains strategic exposure with New York Yankees deal
Published on 09/21/2026 at 15:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Apollo Global Management stock (ISIN US0376123065) is drawing investor attention after reports that the private equity group is nearing a 2.6 billion USD deal for a 16 percent stake in the New York Yankees as of September 21, 2026, adding a high-profile sports asset to its portfolio.
Yankees stake seen as strategic growth move
According to Finimize on September 21, 2026, Apollo Global Management is close to agreeing a 2.6 billion USD transaction that would give it a 16 percent stake in the New York Yankees, implying a valuation of more than 12 billion USD for the franchise.
The report states that Apollo would initially receive 8 percent as common equity and another 8 percent through preferred stock that can convert into common shares after four years, creating a staged entry into the iconic team.
As New York Post reported on September 20, 2026, the structure would see Apollo pay cash up front for the first 8 percent stake and receive preferred stock for the remaining 8 percent, with the investment made via Yankees Global Management, the holding company controlling the Yankees, the YES Network, Legends Hospitality and AC Milan.
Recent earnings and capital deployment
Apollo Global Management’s most recent quarterly figures listed on MarketBeat show that in the quarter reported on August 4, 2026, the firm generated 5.57 billion USD in revenue, slightly below analyst expectations of 5.65 billion USD, and earned 2.11 USD in earnings per share, missing the 2.16 USD consensus by 0.05 USD.
These figures imply that quarterly revenue was about 1.4 percent below expectations, while earnings per share lagged the analyst consensus by roughly 2.3 percent, underscoring a modest shortfall but not a dramatic miss.
MarketBeat also notes that Apollo Global Management had a trailing twelve-month return on equity of 14.01 percent and a net margin of 5.22 percent as of the latest reporting period, indicating a business that generates double-digit returns on equity but with relatively modest net profitability compared with revenue.
In addition to the Yankees transaction, Apollo has been active in deploying capital into corporate deals: an article from Ad-hoc-news on September 21, 2026 references a Bayer partnership in which Apollo provided 3.0 billion EUR of equity, supporting the German group’s long-acting contraceptive business while Bayer retained majority control.
Athene risk update and investor communication
On September 21, 2026, Apollo Global Management filed an 8-K report with the US Securities and Exchange Commission furnishing an Athene risk and stress update presentation under Regulation FD, as highlighted by StockTitan.
The presentation, dated September 2026, provides metrics on Athene’s asset risk profile and stress scenarios, and was furnished rather than filed, signaling that it is meant for transparent communication with investors about risk exposures rather than altering Apollo’s formal financial statements.
According to a news brief on TradingView on September 21, 2026, the Athene presentation was posted on Apollo’s investor site, underlining management’s focus on disclosing how its insurance affiliate’s assets perform under different stress conditions.
This type of risk communication is important context for investors considering the Yankees stake, as it shows Apollo balancing new equity investments with ongoing scrutiny of existing balance-sheet exposures.
Analyst views and valuation context
A commentary piece cited on Yahoo Finance on September 21, 2026 argues that Apollo Global Management stock still looks inexpensive relative to the excess returns it generates, suggesting that the market may not fully price in its ability to earn substantially above its cost of capital.
While the article does not specify a numerical price target, its valuation perspective rests on Apollo’s return profile and fee-generating assets, which could be further enhanced if the Yankees stake delivers steady cash flows and brand-driven growth over time.
Furthermore, a video segment hosted by Bloomberg on September 21, 2026 features the heads of Apollo and other large investors discussing how global capital demand is overwhelming, with significant deployment into defense, energy and artificial intelligence, framing the Yankees deal as one piece of a broader capital allocation landscape.
Stock performance and market metrics
MarketBeat data show that Apollo Global Management stock closed at 125.85 USD on the New York Stock Exchange on September 18, 2026, down 0.12 percent for that trading day, with an extended-hours quote of 125.12 USD as of 7:30 p.m. Eastern time.
The same overview notes that Apollo Global Management’s shares started the year at 144.74 USD and have fallen 13.1 percent year to date to approximately 125.85 USD, a decline of 18.89 USD, which provides a numerical measure of the pullback despite the firm’s active dealmaking.
The MarketBeat page also lists a fiscal year end of December 31, 2026 for Apollo and identifies upcoming calendar items, including participation in Bank of America’s 31st Annual Financials CEO Conference on September 23, 2026 and an estimated next earnings date of November 3, 2026.
Closing price context for Apollo Global Management stock
As of the most recent completed trading day on September 18, 2026, Apollo Global Management stock closed at 125.85 USD on the New York Stock Exchange, roughly 13.1 percent below its 144.74 USD level at the start of the year, reflecting a moderate year-to-date decline even as the company pursues high-profile investments such as the planned New York Yankees stake.
Apollo Global Management stock facts
- Company: Apollo Global Management Inc.
- ISIN: US0376123065
- Ticker: APO
- Trading venue: NYSE
- Price (as of September 18, 2026, 03:59 PM): 125.85 USD
- Market capitalization: [value] USD (as of September 18, 2026)
- Sector / Industry: Financials / Asset Management
- Index membership: S&P 500
- Next earnings date: November 3, 2026
